Results 181 to 190 of about 7,733 (208)

Therapeutic Phlebotomy

open access: yes, 2013
Yelena Z. Ginzburg, Beth H. Shaz
openaire   +2 more sources

Therapeutic Phlebotomy

open access: yes, 2009
Lawrence B. Fialkow, Beth H. Shaz
openaire   +2 more sources

How do I…perform therapeutic phlebotomy?

Transfusion, 2021
AbstractBackgroundTherapeutic phlebotomy (TP) is a well‐established medical intervention that evolved from the historical practice of bloodletting.MethodsPatients who require TP are not infrequently told by their health‐care providers to “just go donate blood,” but TP should always be offered in the context of a prescribed course of therapy.
Alexis R. Peedin, Julie Katz Karp
openaire   +2 more sources

Self-Sustainability with Therapeutic Phlebotomy, a Solution to the National Blood Crisis?

Blood, 2023
CONCLUSION Hereditary hemochromatosis (HH) is a genetic condition associated with iron overload in the human body. The mainstay of treatment remains therapeutic phlebotomy. On August 1st, 2022, the American Red Cross approved using blood obtained from therapeutic phlebotomy for transfusion.
Madhan Srinivasan Kumar   +6 more
openaire   +1 more source

Therapeutic Phlebotomy

Journal of Infusion Nursing, 2010
In the United States, phlebotomies are most often performed for reinfusion of blood to a designated or nondesignated recipient at a later time. These are known, respectively, as autologous or allogenic donations. For a few rare blood disorders, however, phlebotomy is performed as a medical intervention for disease management.
openaire   +2 more sources

Childhood-onset familial porphyria cutanea tarda: Effects of therapeutic phlebotomy

Journal of the American Academy of Dermatology, 1992
Cutaneous fragility at age 2 years with blistering, scarring, milia, and hypertrichosis at age 4 years were noted in an otherwise healthy girl who had no family history of porphyria. Results of porphyrin analyses of urine, serum, and red blood cells revealed a pattern consistent with porphyria cutanea tarda.
M B, Poh-Fitzpatrick   +3 more
openaire   +2 more sources

Adverse effects of therapeutic phlebotomies: Prospective study of 587 procedures

Transfusion
AbstractBackgroundTherapeutic phlebotomy (TP), a widely used medical procedure, can be performed on diverse patients with iron overload or polyglobulia. However, its adverse events are not well known as most of the information on phlebotomy is derived from healthy blood donors (0.1%–5.3%).
Iñigo Romón   +10 more
openaire   +2 more sources

Erythrocyte uroporphyrinogen decarboxylase activity and therapeutic phlebotomy in porphyria cutanea tarda

Journal of Porphyrins and Phthalocyanines, 2000
On the basis of the uroporphyrinogen decarboxylase ( UD ) activity in the erythrocytes, and the family history of the disease, different types of porphyria cutanea tarda ( PCT ) can be distinguished. In some cases, however, the distinction may involve some uncertainty (overlapping of subgroups). The question arises of whether the current erythrocyte UD
FERENC KÓSZÓ   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy